Boston PartnersBoston Partners

Institutional investor · Portfolio as of Q4 2022

SEC EDGAR SourceSEC Filings

Top Holdings696 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

JOHNSON & JOHNSON

8.7M$1.5B2.1%$123.39+30.68%
17 qtrssince 2018-Q4
Decreased
0

JPMORGAN CHASE & CO

9.8M$1.3B1.8%$101.17+22.55%
17 qtrssince 2018-Q4
Decreased
0

AUTOZONE INC

528,970$1.3B1.8%$1,061.78+132.27%
16 qtrssince 2019-Q1
Decreased
0

THE CIGNA GROUP

3.2M$1.1B1.4%$179.22+75.02%
17 qtrssince 2018-Q4
Decreased
0

BRISTOL-MYERS SQUIBB CO

13.8M$992M1.3%$57.93+7.48%
6 qtrssince 2021-Q3
Increased
65

BERKSHIRE HATHAWAY INC-CL B

3.2M$983.9M1.3%$214.01+44.34%
17 qtrssince 2018-Q4
Increased
54

SCHLUMBERGER LTD

17.4M$929.7M1.3%$17.89+175.53%
17 qtrssince 2018-Q4
Decreased
0
SNYSNY
ADR

SANOFI-ADR

18.2M$884M1.2%$39.90+7.47%
6 qtrssince 2021-Q3
Increased
52

DUPONT DE NEMOURS INC

12.7M$877M1.2%$75.25+6.89%
15 qtrssince 2019-Q2
Increased
51

AMERISOURCEBERGEN CORP

5.2M$861.3M1.2%$83.52+92.66%
17 qtrssince 2018-Q4
Increased
52

CENTENE CORP

10.2M$838.1M1.1%$70.41+16.48%
17 qtrssince 2018-Q4
Decreased
0

SCHWAB (CHARLES) CORP

10M$831.3M1.1%$48.01+64.38%
17 qtrssince 2018-Q4
Decreased
0

UNITEDHEALTH GROUP INC

1.6M$830.1M1.1%$304.77+64.68%
17 qtrssince 2018-Q4
Decreased
0

CONOCOPHILLIPS

7M$827.1M1.1%$39.66+169.83%
17 qtrssince 2018-Q4
Decreased
0

HOWMET AEROSPACE INC

20.9M$825.9M1.1%$19.52+99.73%
11 qtrssince 2020-Q2
Decreased
0

ABBVIE INC

5.1M$816.9M1.1%$94.04+50.41%
17 qtrssince 2018-Q4
Decreased
0

CVS HEALTH CORPORATION

8.7M$809.1M1.1%$71.07+14.25%
17 qtrssince 2018-Q4
Increased
54

MARATHON PETROLEUM CORP

6.9M$803M1.1%$48.81+123.38%
17 qtrssince 2018-Q4
Decreased
0

CISCO SYSTEMS INC

16.4M$781.9M1.1%$38.90+10.59%
17 qtrssince 2018-Q4
Increased
54

CENTERPOINT ENERGY INC

25.1M$753.8M1.0%$17.79+55.68%
12 qtrssince 2020-Q1
Increased
50
$73.9B
AUM
696
Positions
Q4 2022
Filing
Rating · 3.0
Quarterly Portfolio Change
+1%Q3'21$78.9B+5%Q4'21$83B-1%Q1'22$82.5B-13%Q2'22$71.6B-5%Q3'22$68.3B+8%Q4'22$73.9B
Activity profile
$ moved · Q4'22
New3%Increased47%Decreased38%Exited11%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.7 years
<1Q6%1-4Q13%1-2Y13%2Y+68%

Boston Partners manages $73.9B across 696 positions as of Q4 2022. Top holdings: JNJ (2.1%), JPM (1.8%), AZO (1.8%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3/5.0.

Q4 2022 Summary

Active quarter - 69 new positions, 94 exits, 321 increased. Top move: BMY (INCREASED, conviction 65). Portfolio: $73.9B across 696 positions.

Top holdings by portfolio weight

Total AUM$74B
JNJ2.07%
JPM1.77%
AZO1.77%
CI1.44%
BMY1.34%
BRK/B1.33%
SLB1.26%
SNY1.20%
DD1.19%
COR1.17%
Other1.13%

Portfolio allocation by GICS sector

Sectors11
Financial Services18.74%
Healthcare17.55%
Industrials14.79%
Technology12.54%
Consumer Cyclical9.64%
Energy7.97%
Basic Materials4.15%
Unknown4.01%
Consumer Defensive2.97%
Utilities2.80%
Other4.84%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Financial Services, Healthcare, Industrials
Compare DNA across all funds
7-dimension quality assessment
Solid(3.0 / 5.0)
Track Record84
Conviction39
Concentration23
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
BKVBKVBKV CORP
Q4 2024 Q2 2026+2.5M shares+$69.4M
7Q
INVAINVAINNOVIVA INC
Q4 2024 Q2 2026+1.6M shares+$37.2M
7Q
KROKROKRONOS WORLDWIDE INC
Q4 2024 Q2 2026+2.3M shares+$9.7M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used